CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted […]
Oral presentation will feature new data for investigational REGN7075, an EGFRxCD28 costimulatory bispecific with the potential to enhance the treatment […]
ThreeD Capital recommends Birchtree shareholders vote “withhold” on all management nominees ThreeD to requisition a shareholder meeting to reconstitute the […]